Containing antigens or hyaluronic acid or its sodium salt
Part of: 300490 — Other:
N344456 · 2024-12-23 — The tariff classification of the ASCENDO™ Submucosal Lifting Agent from South Korea
ASCENDO™ Submucosal Lifting Agent is a single-use, sterile endoscopic lifting solution used in endoscopic procedures to create a cushion-like space between the mucosa and underlining tissue to lift polyps, adenomas, early-stage cancers or other gastrointestinal mucosal lesions prior to excision with a snare or endoscopic device. The main materials of the solution are sodium hyaluronate, methylene blue and normal saline. It is avaible by prescription only in a prefilled disposable 5 mL syringe. The instructions for use you submitted states that the ASCENDO™ Submucosal Lifting Agent is…
N022307 · 2008-01-29 — The tariff classification of Synvisc® Hylan G-F 20 solution put up in single-use glass syringes
According to the insert you submitted, Synvisc® Hylan G-F 20 contains hylan A (average molecular weight 6,000,000) and hylan B hydrated gel in a buffered physiological sodium chloride solution supplied in a 2.25 mL glass syringe containing 2 mL Synvisc. Each syringe of Synvisc contains: Hylan polymers (hylan A + hylan B) 16 mg Sodium chloride 17 mg Disodium hydrogen phosphate 0.32 mg Sodium dihydrogen phosphate monohydrate 0.08 mg Water for injection q.s. to 2.0 mL Hylans are derivatives of hyaluronan (sodium hyaluronate), a substance that comes from, among other sources, chicken combs.…
N004962 · 2007-01-09 — The tariff classification of BD™ OVD 1% from Israel
The BD™ OVD 1% is a single-use ophthalmic viscosurgical device (OVD) consisting of a syringe, with cannula, filled with a viscoelastic preparation containing 10 mg/ml (1%) of sodium hyaluronate (mol. wt.: 3 million daltons) as the active ingredient. The product is indicated for use to protect the corneal endothelium during cataract extraction procedures, intraocular lens (IOL) implantation, and anterior segment surgery. The applicable subheading for the subject product will be 3004.90.1000, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Medicaments…consisting of…
i81075 · 2002-04-25 — The tariff classification of Gelclair™, put up in measured-dose form, from the United Kingdom
, you requested a tariff classification ruling. The subject product, Gelclair™, is a clear viscous gel, put up in measured doses, containing Hyaluronate Sodium (CAS-9067-32-7) and Polyvinylpyrrolidone (CAS-9003-39-8) as the active ingredients. A press release dated January 23, 2002, found on the World Wide Web, indicates the following: “The U.S. Food and Drug Administration (FDA) granted 510(k) clearance to market Gelclair™ in December 2001 for use in the management of pain and relief of pain by adhering to the mucosal surface of the mouth, soothing oral lesions of various etiologies. These…
h89822 · 2002-04-03 — The tariff classification of AMO®Vitrax® Solution (Sodium Hyaluronate), put up in single-use, glass syringes, from Ireland
The subject product, AMO®Vitrax® Solution (Sodium Hyaluronate), consists of a sterile, non-pyrogenic, viscoelastic preparation of a highly purified, non-inflammatory fraction of sodium hyaluronate (the active ingredient), dissolved in a physiological-balanced salt solution. AMO®Vitrax® is indicated for use as a surgical aid in various ophthalmic surgical procedures, such as cataract removal, secondary intraocular lens implantation, and corneal transplantation. AMO®Vitrax® is supplied in single-use, glass syringes, each of which is put up packed for retail sale, along with a 23 gauge,…
Not sure this code fits your product? HaiLang AI determines the US HTS code from a description in about a minute.
Classify a product